3.2K(top 0.1%)
papers
141.6K(top 0.1%)
citations
170(top 0.1%)
h-index
278(top 0.1%)
g-index
3.4K
all documents
151.6K
doc citations
9.0K
citing journals

Top Articles

#TitleJournalYearCitations
1Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic LeukemiaNew England Journal of Medicine20132,019
2Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid CarcinomaThyroid20151,738
3Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence InstrumentsAIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV20001,291
4Medullary Thyroid Cancer: Management Guidelines of the American Thyroid AssociationThyroid20091,247
5Management of a Solitary Thyroid NoduleNew England Journal of Medicine19931,238
6ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer SyndromesAmerican Journal of Gastroenterology20151,204
7Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subsetBlood20011,201
8Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fractureNature Genetics20121,100
9Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic LeukemiaJournal of Experimental Medicine2001978
10Activating ESR1 mutations in hormone-resistant metastatic breast cancerNature Genetics2013925
11Mutations in smooth muscle α-actin (ACTA2) lead to thoracic aortic aneurysms and dissectionsNature Genetics2007767
12CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunityBlood2003750
13PTEN: One Gene, Many SyndromesHuman Mutation2003729
14IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B StudyJournal of Clinical Oncology2010699
15Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765Blood2011689
16Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony.Circulation1989687
17Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytesBlood2013661
18Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B StudyJournal of Clinical Oncology2006618
19MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemiaBlood2008575
20Hostile Marital Interactions, Proinflammatory Cytokine Production, and Wound HealingArchives of General Psychiatry2005556
21The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its LifespanJournal of Experimental Medicine2003537
22Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signalsBlood2010523
23Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLCJournal of Thoracic Oncology2018515
24Phase II Trial of Sorafenib in Metastatic Thyroid CancerJournal of Clinical Oncology2009513
25Differential Cytokine and Chemokine Gene Expression by Human NK Cells Following Activation with IL-18 or IL-15 in Combination with IL-12: Implications for the Innate Immune ResponseJournal of Immunology1999509
26Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Blood2007507
27S-glutathionylation uncouples eNOS and regulates its cellular and vascular functionNature2010507
28Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growthProceedings of the National Academy of Sciences of the United States of America2011498
29Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic LeukemiaJAMA Oncology2015498
30The Broad Spectrum of Human Natural Killer Cell DiversityImmunity2017485
31Will the real Cowden syndrome please stand up: revised diagnostic criteriaJournal of Medical Genetics2000483
32Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem CellsClinical Cancer Research2010478
33Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune responseJournal of Immunology1999461
34Clinical proteomics: Written in bloodNature2003459
35The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesisJournal of Experimental Medicine2005457
36Resistance to Antimicrobial Drugs—A Worldwide CalamityAnnals of Internal Medicine1993450
37Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effectBlood2002449
38Cardiac Mitochondria and Reactive Oxygen Species GenerationCirculation Research2014449
39Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trialLancet Oncology, The2014438
40What does it take to make a natural killer?Nature Reviews Immunology2003437
41The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET proteinCancer Cell2005433
42Human natural killer cell development and biologyBlood Reviews2006425
43Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugsPharmacogenomics Journal2011412
44Psychologic intervention improves survival for breast cancer patientsCancer2008408
45Human natural killer cell developmentImmunological Reviews2006405
46Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomasNature Genetics2002402
47Mutations in Regulatory Subunit Type 1A of Cyclic Adenosine 5′-Monophosphate-Dependent Protein Kinase (PRKAR1A): Phenotype Analysis in 353 Patients and 80 Different GenotypesJournal of Clinical Endocrinology and Metabolism2009399
48Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian CancerJAMA - Journal of the American Medical Association2015390
49Clinical Genetic Testing for Familial HypercholesterolemiaJournal of the American College of Cardiology2018387
50Patient navigation: An update on the state of the scienceCa-A Cancer Journal for Clinicians2011385